CRISPR-Cas9 in Breast Cancer: A Tool for Functional Genomics, Target Discovery, and Precision Therapeutics
- Department of Biotechnology, Vivekanandha College of Arts and Sciences for Women (Autonomous), Elayampalayam, Tiruchengode, Tamil Nadu, India
* Correspondence: gnani@vicas.org
Abstract
CRISPR-Cas9 technology has rapidly emerged as a transformative tool in breast cancer research, enabling precise genome editing that advances functional genomics, target discovery, and therapeutic development. This review highlights the fundamental principles of CRISPR-Cas9 and its diverse applications in breast cancer models, including gene function interrogation and high-throughput screening for oncogenic drivers. We discuss the role of CRISPR-based approaches in advancing precision medicine, such as genome editing for personalized therapies and immune cell engineering. Despite its promising potential, challenges including off-target effects, delivery efficiency, and ethical considerations remain significant barriers to clinical translation. We also explore emerging strategies to overcome these limitations and future directions aimed at optimizing CRISPR technology for improved breast cancer treatment. Integrating CRISPR-Cas9 with multidisciplinary research holds the key to unlocking novel therapeutic avenues and enhancing patient outcomes in the era of precision oncology.
Keywords
Author information
Authors and Affiliations
Department of Biotechnology, Vivekanandha College of Arts and Sciences for Women (Autonomous), Elayampalayam, Tiruchengode, Tamil Nadu, India
Sowmiya Anandan & Gnanendra Shanmugam
Corresponding author
Correspondence to Gnanendra Shanmugam (gnani@vicas.org).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, provided appropriate credit is given to the original author(s) and the source, a link to the licence is provided, and any changes are indicated. Images or other third-party material in this article are included in the article’s licence unless stated otherwise in a credit line to the material. © 2025 The Author(s).
About this article
Cite this article
Anandan S, Shanmugam G. CRISPR-Cas9 in Breast Cancer: A Tool for Functional Genomics, Target Discovery, and Precision Therapeutics. Int J Adv Interdis Res. 2025;5:e009. https://doi.org/10.29191/ijaidr.2025.05.e009
Download citation (RIS) · BibTeX ·
- Received06 May 2025
- Revised16 May 2025
- Accepted18 May 2025
- Published19 May 2025
- DOIhttps://doi.org/10.29191/ijaidr.2025.05.e009
Share this article
Anyone you share the following link with will be able to read this article: